Stay updated on Ferumoxytol MRI in Glioblastoma Response Clinical Trial
Sign up to get notified when there's something new on the Ferumoxytol MRI in Glioblastoma Response Clinical Trial page.

Latest updates to the Ferumoxytol MRI in Glioblastoma Response Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check8 days agoChange DetectedA notice announces updates to NIH websites and says the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence” in some content.SummaryDifference1%

- Check15 days agoChange DetectedThe ClinicalTrials.gov footer revision advances from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedThe site footer revision identifier changed from `v3.7.0` to `v3.7.1`; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, indicating access is blocked. The screen shows a 403 message and related navigation/footer elements reflecting an error state.SummaryDifference20%

- Check64 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a small, non-content-altering update to the study page.SummaryDifference0.1%

Stay in the know with updates to Ferumoxytol MRI in Glioblastoma Response Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ferumoxytol MRI in Glioblastoma Response Clinical Trial page.